Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma.
Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma.
复制标题
胶质母细胞瘤EGFR扩增放射基因组学建模的不确定性量化。
DOI:
10.1038/s41598-021-83141-z
复制
发表时间:
2021-02-16
影响因子:
4.6
通讯作者:
Li J
中科院分区:
文献类型:
--
作者:
Hu LS;Wang L;Hawkins-Daarud A;Eschbacher JM;Singleton KW;Jackson PR;Clark-Swanson K;Sereduk CP;Peng S;Wang P;Wang J;Baxter LC;Smith KA;Mazza GL;Stokes AM;Bendok BR;Zimmerman RS;Krishna C;Porter AB;Mrugala MM;Hoxworth JM;Wu T;Tran NL;Swanson KR;Li J
Radiogenomics uses machine-learning (ML) to directly connect the morphologic and physiological appearance of tumors on clinical imaging with underlying genomic features. Despite extensive growth in the area of radiogenomics across many cancers, and its potential role in advancing clinical decision making, no published studies have directly addressed uncertainty in these model predictions. We developed a radiogenomics ML model to quantify uncertainty using transductive Gaussian Processes (GP) and a unique dataset of 95 image-localized biopsies with spatially matched MRI from 25 untreated Glioblastoma (GBM) patients. The model generated predictions for regional EGFR amplification status (a common and important target in GBM) to resolve the intratumoral genetic heterogeneity across each individual tumor—a key factor for future personalized therapeutic paradigms. The model used probability distributions for each sample prediction to quantify uncertainty, and used transductive learning to reduce the overall uncertainty. We compared predictive accuracy and uncertainty of the transductive learning GP model against a standard GP model using leave-one-patient-out cross validation. Additionally, we used a separate dataset containing 24 image-localized biopsies from 7 high-grade glioma patients to validate the model. Predictive uncertainty informed the likelihood of achieving an accurate sample prediction. When stratifying predictions based on uncertainty, we observed substantially higher performance in the group cohort (75% accuracy, n = 95) and amongst sample predictions with the lowest uncertainty (83% accuracy, n = 72) compared to predictions with higher uncertainty (48% accuracy, n = 23), due largely to data interpolation (rather than extrapolation). On the separate validation set, our model achieved 78% accuracy amongst the sample predictions with lowest uncertainty. We present a novel approach to quantify radiogenomics uncertainty to enhance model performance and clinical interpretability. This should help integrate more reliable radiogenomics models for improved medical decision-making.
登录
查看更多内容
影响因子:
3.6
作者:
Briggs, Andrew H.;Weinstein, Milton C.;Paltiel, A. David
通讯作者:
Paltiel, A. David
影响因子:
15.9
作者:
Hu LS;Eschbacher JM;Heiserman JE;Dueck AC;Shapiro WR;Liu S;Karis JP;Smith KA;Coons SW;Nakaji P;Spetzler RF;Feuerstein BG;Debbins J;Baxter LC
通讯作者:
Baxter LC
影响因子:
17.1
作者:
Itakura H;Achrol AS;Mitchell LA;Loya JJ;Liu T;Westbroek EM;Feroze AH;Rodriguez S;Echegaray S;Azad TD;Yeom KW;Napel S;Rubin DL;Chang SD;Harsh GR 4th;Gevaert O
通讯作者:
Gevaert O
影响因子:
19.7
作者:
Jain, Rajan;Poisson, Laila M.;Flanders, Adam
通讯作者:
Flanders, Adam
DOI:
10.3174/ajnr.a4451
发表时间:
2015-12
期刊:
AJNR. American journal of neuroradiology
影响因子:
--
作者:
Hu LS;Kelm Z;Korfiatis P;Dueck AC;Elrod C;Ellingson BM;Kaufmann TJ;Eschbacher JM;Karis JP;Smith K;Nakaji P;Brinkman D;Pafundi D;Baxter LC;Erickson BJ
通讯作者:
Erickson BJ